Development and validation of a one-step SMN assay for genetic testing in spinal muscular atrophy via MALDI-TOF MS

within a single analytical run. Given its unparalleled cost-effectiveness and time efficiency, this approach holds significant promise for further application in clinical diagnosis as well as newborn screening for SMA.